In another published TCGA pan-cancer pathway analysis, the authors reported 9% and 21% alteration frequencies for the receptor tyrosine kinase RTK/Ras and p53 pathways, respectively, in MPM according to their genomic pathway mapping approach [40]. This evidence concerns the gene TP53 and cancer.